Title:
【発明の名称】NGFに関する治療薬
Document Type and Number:
Japanese Patent JP2002511262
Kind Code:
A
Abstract:
This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF mimetics.
Inventors:
Robertson, Alan, George, Simpson
Allen, Shelley, Jane
David, Dauburn
Allen, Shelley, Jane
David, Dauburn
Application Number:
JP2000543603A
Publication Date:
April 16, 2002
Filing Date:
April 09, 1999
Export Citation:
Assignee:
The University of Bristol
International Classes:
A01K67/027; A61K38/00; A61P25/00; A61P25/04; A61P25/28; A61P29/00; A61P43/00; C07K14/48; C07K14/705; C07K14/71; C07K16/40; C12N1/19; C12N1/21; C12N5/10; C12N9/12; C12N15/09; C12N15/12; C12Q1/48; C12Q1/68; G01N33/15; G01N33/50; G01N33/566; G01N37/00; G06F17/30; (IPC1-7): C12N15/09; A01K67/027; A61K38/00; A61P25/00; A61P25/04; A61P25/28; A61P29/00; A61P43/00; C07K16/40; C12N1/19; C12N1/21; C12N5/10; C12N9/12; C12Q1/48; C12Q1/68; G01N33/15; G01N33/50; G01N33/566; G01N37/00
Attorney, Agent or Firm:
Tsutomu Toyama (4 others)